FrancophonIA/DGT-Translation_Memory huggingface dataset:
English: Tinois, E., Gaetani, Q., Gayraud, B., Dupont, D., Rougier, A., Pouradier, D.X., (1994) The Episkin model: Successful reconstruction of human epidermis in vitro.
French: Tinois E, Gaetani Q, Gayraud B, Dupont D, Rougier A, Pouradier DX (1994). The Episkin model: Successful reconstruction of human epidermis in vitro.
German: Tinois E., Gaetani Q., Gayraud B., Dupont D., Rougier A., Pouradier D.X. (1994).
Spanish: Tinois E, Gaetani Q, Gayraud B, Dupont D, Rougier A, Pouradier DX (1994). The Episkin model: Successful reconstruction of human epidermis in vitro.
Italian: Tinois E, Gaetani Q, Gayraud B, Dupont D, Rougier A, Pouradier DX (1994). The Episkin model: Successful reconstruction of human epidermis in vitro.
Dutch: Tinois E, Gaetani Q, Gayraud B, Dupont D, Rougier A, Pouradier DX (1994). The Episkin model: Successful reconstruction of human epidermis in vitro.
Danish: Tinois E., Gaetani Q., Gayraud B., Dupont D., Rougier A., Pouradier D.X. (1994).
Swedish: Tinois E, Gaetani Q, Gayraud B, Dupont D, Rougier A, Pouradier DX (1994), The Episkin model: Successful reconstruction of human epidermis in vitro.
Finnish: Tinois E, Gaetani Q, Gayraud B, Dupont D, Rougier A, Pouradier DX (1994). The Episkin model: Successful reconstruction of human epidermis in vitro.
Greek: Tinois E, Gaetani Q, Gayraud B, Dupont D, Rougier A, Pouradier DX (1994). The Episkin model: Successful reconstruction of human epidermis in vitro.
Czech: Tinois E, Gaetani Q, Gayraud B, Dupont D, Rougier A, Pouradier DX (1994). The Episkin model: Successful reconstruction of human epidermis in vitro.
Slovak: Tinois E, Gaetani Q, Gayraud B, Dupont D, Rougier A, Pouradier DX (1994). The Episkin model: Successful reconstruction of human epidermis in vitro.
Polish: Tinois E, Gaetani Q, Gayraud B, Dupont D, Rougier A, Pouradier DX (1994). The Episkin model: Successful reconstruction of human epidermis in vitro.
Hungarian: Tinois E, Gaetani Q, Gayraud B, Dupont D, Rougier A, Pouradier DX (1994). The Episkin model: Successful reconstruction of human epidermis in vitro.
Slovenian: Tinois E, Gaetani Q, Gayraud B, Dupont D, Rougier A, Pouradier DX (1994). The Episkin model: Successful reconstruction of human epidermis in vitro.
Estonian: Tinois E, Gaetani Q, Gayraud B, Dupont D, Rougier A, Pouradier DX (1994). The Episkin model: Successful reconstruction of human epidermis in vitro.
Latvian: Tinois E, Gaetani Q, Gayraud B, Dupont D, Rougier A, Pouradier DX (1994). The Episkin model: Successful reconstruction of human epidermis in vitro.
Lithuanian: Tinois E, Gaetani Q, Gayraud B, Dupont D, Rougier A, Pouradier DX (1994). The Episkin model: Successful reconstruction of human epidermis in vitro.
English: Edited by A Rougier, AM Goldberg and HI Maibach, p. 133-140
French: Edited by A Rougier, AM Goldberg and HI Maibach: 133-140
German: Maibach: 133-140.
Spanish: Edited by A Rougier, AM Goldberg and HI Maibach: 133-140
Italian: Edited by A Rougier, AM Goldberg and HI Maibach: 133-140
Dutch: Edited by A Rougier, AM Goldberg and HI Maibach: 133-140
Danish: Edited by A Rougier, AM Goldberg and HI Maibach: 133-140.
Swedish: Edited by A Rougier, AM Goldberg and HI Maibach: s. 133–140
Finnish: Edited by A Rougier, AM Goldberg and HI Maibach: 133–140
Greek: Edited by A Rougier, AM Goldberg and HI Maibach: 133-140
Czech: Edited by A Rougier, AM Goldberg and HI Maibach; 133–140.
Slovak: Edited by A Rougier, AM Goldberg and HI Maibach: 133 – 140
Polish: Edited by A Rougier, AM Goldberg and HI Maibach: 133–140.
Hungarian: Edited by A Rougier, AM Goldberg and HI Maibach: 133–140.
Slovenian: Edited by A Rougier, AM Goldberg and HI Maibach: 133–140
Estonian: Edited by A Rougier, AM Goldberg and HI Maibach: 133-140.
Latvian: Edited by A Rougier, AM Goldberg and HI Maibach: 133–140.
Lithuanian: Edited by A Rougier, AM Goldberg and HI Maibach: p. 133–140.
English: Tinois E, Tiollier J, Gaucherand M, Dumas H, Tardy M, Thivolet J (1991).
German: Tinois E., Tiollier J., Gaucherand M., Dumas H., Tardy M., Thivolet J. (1991).
Spanish: Tinois E, Tiollier J, Gaucherand M, Dumas H, Tardy M, Thivolet J (1991).
Italian: Tinois E, Tiollier J, Gaucherand M, Dumas H, Tardy M, Thivolet J (1991).
Dutch: Tinois E, Tiollier J, Gaucherand M, Dumas H, Tardy M, Thivolet J (1991).
Danish: Tinois E., Tiollier J., Gaucherand M., Dumas H., Tardy M., Thivolet J. (1991).
Finnish: Tinois E, Tiollier J, Gaucherand M, Dumas H, Tardy M, Thivolet J (1991).
Greek: Tinois E, Tiollier J, Gaucherand M, Dumas H, Tardy M, Thivolet J (1991).
Czech: Tinois E, Tiollier J, Gaucherand M, Dumas H, Tardy M, Thivolet J (1991).
Estonian: Tinois E, Tiollier J, Gaucherand M, Dumas H, Tardy M, Thivolet J (1991).
Lithuanian: Tinois E, Tiollier J, Gaucherand M, Dumas H, Tardy M, Thivolet J (1991).
English: In vitro and post–transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute.
French: In vitro and post — transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute.
German: In vitro and post -transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute.
Spanish: In vitro and post -transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute.
Italian: In vitro and post -transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute.
Dutch: In vitro and post -transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute.
Danish: In vitro and post -transplantation differentiation of humankeratinocytes grown on the human type IV collagen film of a bilayereddermal substitute.
Finnish: In vitro and post -transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute.
Greek: In vitro and post –transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute.
Czech: In vitro and post – transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute.
Slovak: In vitro and post-transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute.
Polish: In vitro and post -transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute.
Hungarian: In vitro and post-transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute.
Slovenian: In vitro and post -transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute.
Estonian: In vitro and post -transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute.
Latvian: In vitro and post –transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute.
Lithuanian: In vitro and post –transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute.
English: Experimental Cell Research 193, p. 310-319
French: Experimental Cell Research 193: 310-319
German: Experimental Cell Research 193, 310-319.
Spanish: Experimental Cell Research 193:310-319
Italian: Experimental Cell Research 193: 310-319
Dutch: Experimental Cell Research 193: 310-319
Danish: Experimental Cell Research 193: 310-319.
Swedish: Experimental Cell Research 193:310-319
Finnish: Experimental Cell Research 193: 310–319
Greek: Experimental Cell Research 193: 310-319
Czech: Experimental Cell Research 193; 310-319.
Slovak: Experimental Cell Research 193: 310 – 319
Polish: Experimental Cell Research 193: 310–319.
Hungarian: Experimental Cell Research 193: 310–319.
Slovenian: Experimental Cell Research 193: 310–319
Estonian: Experimental Cell Research 193: 310-319.
Latvian: Experimental Cell Research 193: 310–319.
Lithuanian: Experimental Cell Research 193: p. 310–319.
English: Cytotechnology 9, p. 163-171.
French: Cytotechnology 9, 163-171.
German: Cytotechnology 9, 163-171.
Spanish: Cytotechnology 9, 163-171.
Italian: Cytotechnology 9, 163-171.
Dutch: Cytotechnology 9, 163-171.
Danish: Cytotechnology 9, 163-171.
Swedish: Cytotechnology 9, s. 163–171.
Finnish: Cytotechnology 9, 163–171.
Greek: Cytotechnology 9, 163-171.
Czech: Cytotechnology 9, 163–171.
Slovak: Cytotechnology 9, 163 – 171.
Polish: Cytotechnology 9, 163–171.
Hungarian: Cytotechnology 9, 163–171.
Slovenian: Cytotechnology 9, 163–171.
Estonian: Cytotechnology 9, 163-171.
Latvian: Cytotechnology 9, p. 163–171.
Lithuanian: Cytotechnology 9, p. 163–171.
English: Wilkins, L.M., Watson, S.R., Prosky, S.J., Meunier, S.F., Parentau, N.L., (1994) Development of a bilayered living skin construct for clinical applications.
French: Wilkins, L.M., Watson, S.R., Prosky, S.J., Meunier, S.F., Parentau, NX. (1994). Development of a bilayered living skin construct for clinical applications.
German: Wilkins, L.M., Watson, S.R., Prosky, S.J., Meunier, S.F., Parentau, N.L. (1994). Development of a bilayered living skin construct for clinical applications.
Spanish: Wilkins, L.M., Watson, S.R., Prosky, S.J., Meunier, S.F., Parentau, N.L. (1994). Development of a bilayered living skin construct for clinical applications.
Italian: Wilkins, L.M., Watson, S.R., Prosky, S.J., Meunier, S.F., Parentau, N.L. (1994). Development of a bilayered living skin construct for clinical applications.
Dutch: Wilkins, L.M., Watson, S.R., Prosky, S.J., Meunier, S.F., Parentau, N.L. (1994). Development of a bilayered living skin construct for clinical applications.
Danish: Wilkins, L.M., Watson, S.R., Prosky, S.J., Meunier, S.F., Parentau, N.L. (1994). Development of a bilayered living skin construct for clinical applications.
Swedish: Wilkins, L.M., Watson, S.R., Prosky, S.J., Meunier, S.F., Parentau, N.L. (1994), Development of a bilayered living skin construct for clinical applications.
Finnish: Wilkins, L.M., Watson, S.R., Prosky, S.J., Meunier, S.F., Parentau, N.L. (1994). Development of a bilayered living skin construct for clinical applications.
Greek: Wilkins, L.M., Watson, S.R., Prosky, S.J., Meunier, S.F., Parentau, N.L. (1994). Development of a bilayered living skin construct for clinical applications.
Czech: Wilkins, L.M., Watson, S.R., Prosky, S.J., Meunier, S.F., Parentau, N.L. (1994). Development of a bilayered living skin construct for clinical applications.
Slovak: Wilkins, L.M., Watson, S.R., Prosky, S.J., Meunier, S.F., Parentau, N.L. (1994). Development of a bilayered living skin construct for clinical applications.
Polish: Wilkins, L.M., Watson, S.R., Prosky, S.J., Meunier, S.F., Parentau, N.L. (1994). Development of a bilayered living skin construct for clinical applications.
Hungarian: Wilkins, L.M., Watson, S.R., Prosky, S.J., Meunier, S.F., Parentau, N.L. (1994). Development of a bilayered living skin construct for clinical applications.
Slovenian: Wilkins, L.M., Watson, S.R., Prosky, S.J., Meunier, ST., Parentau, N.L. (1994). Development of a bilayered living skin construct for clinical applications.
Estonian: Wilkins, L.M., Watson, S.R., Prosky, S.J., Meunier, S.F., Parentau, N.L. (1994). Development of a bilayered living skin construct for clinical applications.
Latvian: Wilkins, L.M., Watson, S.R., Prosky, S.J., Meunier, S.F., Parentau, N.L. (1994). Development of a bilayered living skin construct for clinical applications.
Lithuanian: Wilkins, L.M., Watson, S.R., Prosky, S.J., Meunier, S.F., Parentau, N.L. (1994). Development of a bilayered living skin construct for clinical applications.
English: Biotechnology and Bioengineering 43/8, p. 747-756.
French: Biotechnology and Bioengineering 43/8. 747-756.
German: Biotechnology and Bioengineering 43/8, 747-756.
Spanish: Biotechnology and Bioengineering 43/8, 747-756.
Italian: Biotechnology and Bioengineering 43/8, 747-756.
Dutch: Biotechnology and Bioengineering 43/8, 747-756.
Danish: Biotechnology and Bioengineering 43/8, 747-756.
Swedish: Biotechnology and Bioengineering 43/8, s. 747–756.
Finnish: Biotechnology and Bioengineering 43/8, 747–756.
Greek: Biotechnology and Bioengineering 43/8, 747-756.
Czech: Biotechnology and Bioengineering 43/8, 747–756.
Slovak: Biotechnology and Bioengineering 43/8, 747 – 756.
Polish: Biotechnology and Bioengineering 43/8, 747–756.
Hungarian: Biotechnology and Bioengineering 43/8, 747–756.
Slovenian: Biotechnology and Bioengineering 43/8, 747–756.
Estonian: Biotechnology and Bioengineering 43/8, 747-756.
Latvian: Biotechnology and Bioengineering 43/8, p. 747–756.
Lithuanian: Biotechnology and Bioengineering 43/8, p. 747–756.
English: Marshall, N.J., Goodwin, C.J., Holt, S.J., (1995) A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function.
French: Marshall, N.J., Goodwin, C.J., Holt, SJ. (1995). A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function.
German: Marshall, N.J., Goodwin, C.J., Holt, S.J. (1995). A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function.
Spanish: Marshall, N.J., Goodwin, C.J., Holt, S.J. (1995). A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function.
Italian: Marshall, N.J., Goodwin, C.J., Holt, S.J. (1995). A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function.
Dutch: Marshall, N.J., Goodwin, C.J., Holt, SJ. (1995). A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function.
Danish: Marshall, N.J., Goodwin, C.J., Holt, S.J. (1995). A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function.
Swedish: Marshall, N.J., Goodwin, C.J., Holt, S.J. (1995), A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function.
Finnish: Marshall, N.J., Goodwin, C.J., Holt, S.J. (1995). A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function.
Greek: Marshall, N.J., Goodwin, C.J., Holt, S.J. (1995). A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function.
Czech: Marshall, N.J., Goodwin, C.J., Holt, S.J. (1995). A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function.
Slovak: Marshall, N.J., Goodwin, C.J., Holt, S.J. (1995). A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function.
Polish: Marshall, N.J., Goodwin, C.J., Holt, S.J. (1995). A critical assessment of the use of microculture tetrazohum assays to measure cell growth and function.
Hungarian: Marshall, N.J., Goodwin, C.J., Holt, S.J. (1995). A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function.
Slovenian: Marshall, N.J., Goodwin, C.J., Holt, S.J. (1995). A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function.
Estonian: Marshall, N.J., Goodwin, C.J., Holt, S.J. (1995). A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function.
Latvian: Marshall, N.J., Goodwin, C.J., Holt, S.J. (1995). A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function.
Lithuanian: Marshall, N.J., Goodwin, C.J., Holt, S.J. (1995). A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function.
English: Growth Regulation 5, p. 69-84.
French: Growth Regulation 5, 69- 84.
German: Growth Regulation 5, 69-84.
Spanish: Growth Regulation 5, 69-84.
Italian: Growth Regulation 5, 69-84.
Dutch: Growth Regulation 5, 69-84.
Danish: Growth Regulation 5, 69-84.
Swedish: Growth Regulation 5, s. 69–84.
Finnish: Growth Regulation 5, 69–84.
Greek: Growth Regulation 5, 69-84.
Czech: Growth Regulation 5, 69–84.
Slovak: Growth Regulation 5, 69 – 84.
Polish: Growth Regulation 5, 69–84.
Hungarian: Growth Regulation 5, 69–84.
Slovenian: Growth Regulation 5, 69–84.
Estonian: Growth Regulation 5, 69-84.
Latvian: Growth Regulation 5, p. 69–84.
Lithuanian: Growth Regulation 5, p. 69–84.
English: Toxicology In Vitro 15, p. 57-93.
French: In Vitro 15, 57-93.
German: InVitro 15, 57-93.
Spanish: In Vitro 15, 57-93.
Italian: InVItro 15, 57-93.
Dutch: In Vitro 15, 57-93.
Danish: In VItro 15, 57-93.
Swedish: InVitro 15, s. 57–93.
Finnish: InVItro 15, 57–93.
Greek: InVItro 15, 57-93.
Czech: InVItro 15, 57–93.
Slovak: In Vitro 15, 57 – 93.
Polish: InVItro 15, 57–93.
Hungarian: In vitro 15, 57–93.
Slovenian: In Vitro 15, 57–93.
Estonian: In Vitro J15, 57-93.
Latvian: Toxicology In Vitro 15, p. 57–93.
Lithuanian: InVitro 15, p. 57–93.
English: This method is equivalent to OECD TG 432 (2004).
French: Cette méthode d'essai est équivalente à la ligne directrice 432 (2004) de l'OCDE.
German: Diese Methode entspricht OECD TG 432 (2004).
Spanish: El presente método es equivalente a las directrices de ensayo de la OCDE TG 432 (2004).
Italian: Questo metodo corrisponde alle linee guida OCSE TG 432 (2004).
Portuguese: Este método é equivalente ao OECD TG 432 (2004).
Dutch: Deze methode komt overeen met OESO TG 432 (2004).
Danish: Denne metode er ækvivalent med OECD TG 432 (2004).
Swedish: Denna testmetod motsvarar OECD TG 432 (2004).
Finnish: Tämä menetelmä vastaa OECD:n testiohjetta nro 432 (2004).
Greek: Η παρούσα μέθοδος είναι ισοδύναμη με την κατευθυντήρια γραμμή δοκιμών TG 432 (2004) του ΟΟΣΑ.
Czech: Tato zkušební metoda je rovnocenná metodě OECD TG 432 (2004).
Slovak: Táto metóda je ekvivalentná OECD TG 432 (2004).
Polish: Opisywana metoda testowa jest zgodna z OECD TG 432 (2004).
Hungarian: Ez a vizsgálati módszer egyenértékű az OECD TG 432 (2004) számú vizsgálattal.
Slovenian: Ta preskusna metoda je enakovredna OECD TG 432 (2004).
Estonian: Käesolev meetod vastab suunisele OECD TG 432 (2004).
Latvian: Šī metode ir ekvivalenta ESAO TG 432 (2004) metodei.
Lithuanian: Šis metodas atitinka OECD TG 432 (2004).
English: Many types of chemicals have been reported to induce phototoxic effects (1)(2)(3)(4).
French: Des effets phototoxiques ont été signalés pour de nombreux types de produits chimiques (1) (2) (3) (4).
German: Fototoxische Wirkung wurde bei zahlreichen Arten von Chemikalien beobachtet (1) (2) (3) (4).
Spanish: Se han señalado numerosos tipos de sustancias químicas que producen efectos fototóxicos (1) (2) (3) (4).
Italian: È noto che molti tipi di sostanze chimiche inducono effetti fototossici (1)(2)(3)(4).
Portuguese: Têm sido referidos os efeitos fototóxicos induzidos por muitos tipos de substâncias químicas (1) (2) (3) (4).
Dutch: Van veel soorten chemische stoffen is gerapporteerd dat ze fototoxische effecten induceren (1)(2)(3)(4).
Danish: Der er rapporteret om mange typer kemiske stoffer, der fremkalder fototoksiske virkninger (1)(2)(3)(4).
Swedish: Många typer av kemikalier har rapporterats ge upphov till fototoxiska effekter (1)(2)(3)(4).
Finnish: Useantyyppisten kemikaalien on ilmoitettu olevan valomyrkyllisiä (1) (2) (3) (4).
Greek: Υπάρχουν διάφοροι τύποι χημικών ουσιών που έχουν αναφερθεί ως φωτοτοξικές (1)(2)(3)(4).
Czech: Fototoxické účinky byly zaznamenány u mnoha typů chemických látek (1, 2, 3, 4).
Slovak: Uvádza sa, že mnohé druhy chemických látok indukujú fototoxické účinky (1), (2), (3), (4).
Polish: Wiadome jest, że wiele rodzajów substancji chemicznych wywołuje efekt fototoksyczny (1)(2)(3)(4).
Hungarian: Számos különböző vegyi anyagról megállapították, hogy fototoxikus hatást váltanak ki (1) (2) (3) (4).
Slovenian: Za več vrst kemikalij je bilo ugotovljeno, da sprožajo fototoksične učinke (1) (2) (3) (4).
Estonian: Fototoksiline mõju on leitud paljudel kemikaaliliikidel (viited 1–4).
Latvian: Daudzām ķīmisko vielu klasēm aprakstīta to spēja izraisīt fototoksisku iedarbību (1) (2) (3) (4).
Lithuanian: Apie daug cheminių medžiagų rūšių yra paskelbta, jog jos sukelia fototoksinį poveikį (1) (2) (3) (4).
English: Their common feature is their ability to absorb light energy within the sunlight range.
French: Le point commun entre ces derniers est leur capacité à absorber l'énergie lumineuse dans la plage de la lumière solaire.
German: Gemeinsames Merkmal dieser Chemikalien ist, dass sie Lichtenergie im Sonnenlichtbereich absorbieren können.
Spanish: Tienen en común la capacidad de absorber energía luminosa del espectro de la luz solar.
Italian: La caratteristica che le accomuna è la capacità di assorbire l'energia luminosa nello spettro della luce solare.
Portuguese: A característica comum dessas substâncias é a capacidade de absorverem energia luminosa da radiação solar.
Dutch: Deze hebben als gemeenschappelijk kenmerk dat ze lichtenergie binnen het zonlichtspectrum kunnen absorberen.
Danish: Et fælles træk er deres evne til at absorbere lysenergi inden for sollysets spektrum.
Swedish: Deras gemensamma egenskap är förmågan att absorbera ljusenergi inom solljusets våglängdsområde.
Finnish: Niiden yhteinen ominaisuus on kyky absorboida energiaa auringonvalon spektrialueella.
Greek: Το κοινό χαρακτηριστικό τους είναι η ικανότητά τους να απορροφούν φωτεινή ενέργεια στη περιοχή μηκών κύματος του ηλιακού φωτός.
Czech: Jejich společným rysem je schopnost absorbovat světelnou energii v oblasti slunečního světla.
Slovak: Spoločnou črtou je ich schopnosť absorbovať svetelnú energiu slnečného svetla.
Polish: Ich wspólną cechą jest zdolność do absorbowania energii światła w zakresie widma odpowiadającego widmu promieniowania słonecznego.
Hungarian: Ezek közös tulajdonsága, hogy képesek a napfénytartományon belül fényenergiát elnyelni.
Slovenian: Njihova edina skupna lastnost je sposobnost, da v območju sončne svetlobe absorbirajo svetlobno energijo.
Estonian: Nende ühine omadus on võime neelata valgusenergiat päikesevalguse lainepikkustel.
Latvian: Šīm vielām piemīt spēja absorbēt gaismas staru enerģiju redzamās gaismas diapazonā.
Lithuanian: Visų jų bendra savybė – gebėjimas sugerti saulės šviesos bangų ilgio energiją.